3 months ago
JNJ
AnalystsTim AndersonTim Anderson's Stock Forecasts
AnalystsTim Anderson
Sectors:
Industries:
Analyst Ranking
Top 27%
#1346 out of 4929 analysts
Average Return
+10.94%
Win Rate
67%12 out of 18
Risk vs Reward
Poor
Good
Tim Anderson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Aardvark Therapeutics IncAARD | +56.40% | $8.90 | $13.92 | 2025-03-27 - 2025-07-03 | Strong Buy |
Aardvark Therapeutics IncAARD | +35.67% | $10.26 | $13.92 | 2025-03-10 - 2025-07-03 | Strong Buy |
Abbvie IncABBV | +30.45% | $114.68 | $149.60 | 2021-05-03 - 2022-05-03 | Buy |
Regeneron Pharmaceuticals IncREGN | +29.69% | $778.50 | $547.36 | 2024-12-10 - 2025-07-03 | Sell |
Moderna IncMRNA | +26.55% | $41.51 | $30.49 | 2024-12-10 - 2025-07-03 | Sell |
Tim Anderson Analyst Color
Get additional color on Tim Anderson's coverage of popular stocks
4 months ago
GILD
5 months ago
MRK
5 months ago
JNJ
6 months ago
JNJ
7 months ago
PFE
7 months ago
LLY
Tim Anderson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals IncREGN | 2 | Sell | $547.00 | -0.07% | Maintains | 3 months ago |
Johnson & JohnsonJNJ | 5 | Hold | $159.00 | +1.92% | Maintains | 3 months ago |
Aardvark Therapeutics IncAARD | 2 | Strong Buy | $26.00 | +86.78% | Maintains | 3 months ago |
Gilead Sciences IncGILD | 3 | Strong Buy | $126.00 | +12.75% | Maintains | 4 months ago |
Amgen IncAMGN | 3 | Sell | $294.00 | -1.42% | Maintains | 4 months ago |
Abbvie IncABBV | 4 | Hold | $223.00 | +17.81% | Maintains | 4 months ago |
Metsera IncMTSR | 1 | Strong Buy | $38.00 | +29.03% | Initiates Coverage On | 4 months ago |
Moderna IncMRNA | 2 | Sell | $34.00 | +11.51% | Maintains | 5 months ago |
Merck & Co IncMRK | 4 | Strong Buy | $112.00 | +38.39% | Maintains | 5 months ago |
Pfizer IncPFE | 1 | Hold | $29.00 | +14.26% | Reinstates | 7 months ago |
Bristol Myers Squibb CoBMY | 1 | Hold | $63.00 | +34.27% | Reinstates | 7 months ago |
Biogen IncBIIB | 1 | Hold | $178.00 | +33.97% | Reinstates | 7 months ago |
Eli Lilly & CoLLY | 1 | Strong Buy | $997.00 | +27.71% | Reinstates | 7 months ago |
Novartis AgNVS | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.